Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0001171843-17-007110

Director bought 15,000 shares at $2.22 ($33,281)

From the SEC's structured data for this filing

Trades in this filing

AZAB MOHAMMAD · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2017-11-15 Purchase : show line 1 in the form +15,000 $2.22 $33,281 44,210 D
Open-market purchases · 15,000 sh · avg $2.22 · $33,281
Loading xslF345X03/formfour.xml…